Select Medical Holdings Corporation (SEM)
USD 18.28
(-4.39%)
USD 18.28
(-4.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 582.05 Million | 284.82 Million | 401.22 Million | 1.02 Billion | 445.18 Million | 494.19 Million |
| Net Income | 299.73 Million | 198.02 Million | 499.94 Million | 344.6 Million | 201.03 Million | 176.94 Million |
| Depreciation & Amortization | 208.74 Million | 205.82 Million | 202.64 Million | 205.65 Million | 212.57 Million | 201.65 Million |
| Deferred income taxes | -16.11 Million | 7.52 Million | 5.05 Million | -14.71 Million | -7.43 Million | 7.21 Million |
| Stock-based compensation | 43.8 Million | 37.75 Million | 30.94 Million | 27.25 Million | 26.45 Million | 23.32 Million |
| Change in working capital | 59.49 Million | -159.53 Million | -329.97 Million | 479.09 Million | -13.08 Million | 84.39 Million |
| Other non-cash items | -13.6 Million | -4.76 Million | -7.38 Million | -13.82 Million | 25.64 Million | 656 Thousand |
| Investing Cash Flow | -268.47 Million | -226.33 Million | -256.59 Million | -115.35 Million | -316.72 Million | -697.13 Million |
| Investments in PPE | -229.2 Million | -190.37 Million | -180.53 Million | -146.44 Million | -157.12 Million | -167.28 Million |
| Acquisitions | -39.44 Million | -44.31 Million | -102.87 Million | -52.23 Million | -159.79 Million | -536.61 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 163 Thousand | 8.34 Million | 26.82 Million | 83.32 Million | 192 Thousand | 6.76 Million |
| Financing Cash Flow | -327.48 Million | -34.89 Million | -647.38 Million | -671.54 Million | 32.25 Million | 255.57 Million |
| Debt repayment | -203.95 Million | -870.59 Million | -39.66 Million | -558.22 Million | -3.1 Billion | -846.12 Million |
| Dividends payments | -63.9 Million | -64.58 Million | -50.6 Million | - | - | - |
| Common Stock Repurchased | -12.75 Million | -195.52 Million | -79.47 Million | -16.03 Million | -38.53 Million | -6.83 Million |
| Common Stock Issuance | - | - | 235.36 Million | - | 964 Thousand | 1.72 Million |
| Other Financing Activities | -46.86 Million | 1.09 Billion | -713 Million | -97.28 Million | 3.17 Billion | 1.1 Billion |
| Accounts receivables | 1.15 Million | -52.18 Million | 23.1 Million | -116.6 Million | -57.99 Million | 54.57 Million |
| Accounts payables | -6.41 Million | -48.04 Million | 53.39 Million | 27.32 Million | 5.74 Million | 26.11 Million |
| Inventory | - | - | -82.77 Million | 167.65 Million | 33.03 Million | - |
| Other working capital | 64.75 Million | -59.31 Million | -323.69 Million | 400.72 Million | 6.12 Million | 3.7 Million |
| Cash at beginning of period | 97.9 Million | 74.31 Million | 577.06 Million | 335.88 Million | 175.17 Million | 122.54 Million |
| Cash at end of period | 84 Million | 97.9 Million | 74.31 Million | 577.06 Million | 335.88 Million | 175.17 Million |
| Capital Expenditure | -229.2 Million | -190.37 Million | -180.53 Million | -146.44 Million | -157.12 Million | -167.28 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -13.9 Million | 23.59 Million | -502.75 Million | 241.17 Million | 160.7 Million | 52.62 Million |
| Free Cash Flow | 352.85 Million | 94.45 Million | 220.69 Million | 881.63 Million | 288.05 Million | 326.91 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 125.21 Million | 74.23 Million | 93.49 Million | 61.79 Million | 299.73 Million | 60.81 Million |
| Depreciation & Amortization | 50.14 Million | 53.93 Million | 54.06 Million | 53.98 Million | 208.74 Million | 52.39 Million |
| Deferred income taxes | -602 Thousand | -27.44 Million | -6.89 Million | 930 Thousand | -16.11 Million | -6.17 Million |
| Stock-based compensation | 13.37 Million | 14.41 Million | 11.61 Million | 11.81 Million | 43.8 Million | 11.48 Million |
| Change in working capital | 99.48 Million | 146.75 Million | -246.24 Million | 46.95 Million | 59.49 Million | 7.06 Million |
| Other non-cash items | -106.64 Million | 84.23 Million | 348.04 Million | 3.95 Million | -13.6 Million | -9.25 Million |
| Investing Cash Flow | -50.84 Million | -48.31 Million | -57.65 Million | -69.58 Million | -268.47 Million | -63.01 Million |
| Investments in PPE | 108.06 Million | -55.54 Million | -52.51 Million | -60.6 Million | -229.2 Million | -50.19 Million |
| Acquisitions | -4.4 Million | 7.23 Million | -5.14 Million | -9.08 Million | -39.44 Million | -12.82 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -154.5 Million | 2.06 Million | 265 Thousand | 103 Thousand | 163 Thousand | 4000.00 |
| Financing Cash Flow | -49.81 Million | -211.29 Million | 132.96 Million | -103.29 Million | -327.48 Million | -77.04 Million |
| Debt repayment | -341.95 Million | -184.1 Million | -157.84 Million | -73.07 Million | -203.95 Million | -26.33 Million |
| Dividends payments | -16.19 Million | -16.25 Million | -16.04 Million | -16.04 Million | -63.9 Million | -16.03 Million |
| Common Stock Repurchased | -16.52 Million | -1.4 Million | - | -1.7 Million | -12.75 Million | -9.54 Million |
| Common Stock Issuance | 511.19 Million | - | - | -2.51 Billion | - | - |
| Other Financing Activities | 324.85 Million | -9.53 Million | -8.83 Million | -12.45 Million | -46.86 Million | -25.13 Million |
| Accounts receivables | 22.34 Million | 56.19 Million | -195.3 Million | 4.17 Million | 1.15 Million | 20.12 Million |
| Accounts payables | 5.55 Million | -1.89 Million | -5.71 Million | -11.2 Million | -6.41 Million | -2.3 Million |
| Inventory | - | - | - | -2.3 Million | - | 2.3 Million |
| Other working capital | -47.23 Million | 92.45 Million | -45.21 Million | 56.29 Million | 64.75 Million | -13.05 Million |
| Cash at beginning of period | 111.16 Million | 92.62 Million | 84 Million | 77.44 Million | 97.9 Million | 101.16 Million |
| Cash at end of period | 191.46 Million | 111.16 Million | 92.62 Million | 84 Million | 84 Million | 77.44 Million |
| Capital Expenditure | 108.06 Million | -55.54 Million | -52.51 Million | -60.6 Million | -229.2 Million | -50.19 Million |
| Effect of forex changes on cash | - | - | - | -23.81 Million | - | 23.81 Million |
| Net cash flow / Change in cash | 80.3 Million | 18.54 Million | 8.61 Million | 6.56 Million | -13.9 Million | -23.72 Million |
| Free Cash Flow | 289.03 Million | 222.6 Million | -119.2 Million | 118.83 Million | 352.85 Million | 66.14 Million |
JG
600460
9933
9919
1785
EXN